An access port for providing subcutaneous access to a patient is disclosed. In one embodiment, the port includes an internal body defining a fluid cavity that is accessible via a septum. A compliant outer cover including silicone is disposed about at least a portion of the body. A flange is included with the port body and is covered by the outer cover. The flange radially extends about a perimeter of the port body proximate the septum so as to impede penetration of a needle substantially into the outer cover in instances where the needle misses the septum. The flange can further include both an anchoring feature for securing the outer cover to the port body and an identification feature observable via x-ray imaging technology for conveying information indicative of at least one attribute of the access port. The outer cover provides a suitable surface for application of an antimicrobial/antithrombotic coating.

The device includes a manipulation mechanism for maneuvering a base into position proximate a subcutaneous port. Arms extending from the base enable the device to receive the port and substantially immobilize the port relative to the device. The manipulation mechanism also enables a user to substantially immobilize the device relative to a patient. With the subcutaneous port substantially immobilized by the device, the user has greater confidence and accuracy when inserting a needle into the port. Further, embodiments of the device provide protection to the user to prevent inadvertent sticking of the user as the needle is introduced.

A subcutaneous vein access port implanted into a living body to be connected to a subcutaneous vein, includes: a housing formed therein with a receiving portion to which a medicine is supplied; a cover membrane disposed at an upper end of the housing and sealing an upper side of the receiving portion; a conduit provided to the housing and inserted into the subcutaneous vein to connect the subcutaneous vein to the receiving portion; and a light source emitting light such that the light from the light source is discharged outside through the cover membrane.

Fluid delivery systems and methods of delivering an agent and treating a disorder are disclosed that include a subcutaneously implantable port having a body defining a chamber with an open top and a delivery opening and a septum coupled to the body to extend over the open top of the chamber. The systems and methods can further include an intrathecal catheter having an proximal end configured to be coupled to the port and fluidly coupled to the delivery opening of the chamber and a plug having a body with a passage to receive the intrathecal catheter therethrough. The plug can be configured to be inserted into the fascia to protect against leakage of cerebrospinal fluid.

A percutaneous access device comprises a frame, a hatch and a hinge that couples the frame to the hatch. The frame has a passageway that extends therethrough. When the percutaneous access device is implanted in a patient, the frame is positioned beneath a layer of skin of the patient against a bodily vessel. Moreover, the hinge biases the hatch closed against the frame in a normally closed position such that liquid flowing through a lumen of the vessel cannot escape through the percutaneous access device. However, the application of force against the hatch from an object (such as a needle) that extends through the passageway causes the hatch to open outwardly from the frame and into the lumen of the vessel. Correspondingly, the hinge biases the hatch back to the normally closed position upon removal of the object.

An implantable vascular access port has a main port body with one or more hollow internal chambers formed therein each with a floor at the base of the internal chamber. The port body has an outlet aperture formed in a sidewall there of the internal chamber. One or more parallel, lateral, or angled-access apertures, relative to the port floor and associated septa are located opposite the outlet aperture in the main port body in a sidewall there of (parallel or lateral or angled-access aperture or septum), with at least a one perpendicular-access aperture and septum located opposite the floor of the internal chamber(s). The port chamber in the area of the outlet aperture has an at least partially conical shape directionally aligned with the parallel or lateral or angled-access aperture and septum, with said outlet aperture in contiguity a reversible outlet tube or port body needle locking mechanism.

Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.

A method for manufacturing an implantable access port, including forming a port body. The port body can include a fluid cavity located in a central region, the fluid cavity having a base surface lying in a first plane, and a plurality of recessed sections located in a peripheral region surrounding the central region, the plurality of recessed sections having a depth extending from a bottom surface of the peripheral region through the first plane. The method further includes locating a septum over the fluid cavity, and positioning a radiopaque insert in the plurality of recessed sections.

An implantable vascular access port has a main port body with one or more hollow internal chambers formed therein each with a floor at the base of the internal chamber. The port body has an outlet aperture formed in a sidewall there of the internal chamber. One or more parallel, lateral, or angled-access apertures, relative to the port floor and associated septa are located opposite the outlet aperture in the main port body in a sidewall there of (parallel or lateral or angled-access aperture or septum), with at least a one perpendicular-access aperture and septum located opposite the floor of the internal chamber(s). The port chamber in the area of the outlet aperture has an at least partially conical shape directionally aligned with the parallel or lateral or angled-access aperture and septum, with said outlet aperture in contiguity a reversible outlet tube or port body needle locking mechanism.

In certain systems disclosed herein, one or more of a first vascular access port and a second vascular access port can be selected by a customer. Each of the first and second vascular access ports can be implanted subcutaneously within a patient, and each can include a base configured to be attached to a vessel, a body that extends away from the base, and a guidance passageway that extends through the body and the base and includes a funnel region. A maximum height defined by the base and body of the second vascular access port can be greater than a maximum height defined by the base and body of the first vascular access port.